Purification and in vitro characterization of Trypanosoma brucei prolyl-tRNA synthetase

Loading...
Thumbnail Image

Date

2022-05

Journal Title

Journal ISSN

Volume Title

Publisher

The Ohio State University

Research Projects

Organizational Units

Journal Issue

Abstract

Housekeeping proteins include a broad variety of enzymes that complete the basic tasks necessary for cell survival. Among this group, aminoacyl-tRNA synthetases (aaRSs) function to attach the correct amino acid to the cognate tRNA substrate in a reaction known as aminoacylation. The aminoacyl-tRNA is delivered to the ribosome by an elongation factor, where it participates in protein synthesis. While catalysis of the aminoacylation reaction seems straightforward, aaRSs must sample similarly sized amino acids to find a match for the protein active site. Amino acids with the same or smaller molecular volume can fit into the active site and become mistakenly charged to noncognate tRNA. Thus, the cell uses proofreading mechanisms to ensure that only cognate aminoacyl-tRNAs arrive at the ribosome. In the context of charging L-proline to tRNAPro, prolyl-tRNA synthetase (ProRS) frequently mischarges alanine and cysteine and generates Ala-tRNAPro and Cys-tRNA Pro. The bacterial Escherichia coli enzyme, for example, relies on an insertion (INS) domain in its ProRS architecture to hydrolyze mischarged Ala-tRNAPro species. Other prokaryotes such as Caulobacter crescentus, lack this embedded domain but encode a homologous, free-standing editing factor, ProXp-ala, for the same function. Beyond prokarya, however, understanding of eukaryotic editing processes remains limited. Homo sapiens and other higher eukaryotes also possess a free-standing ProXp ala domain for editing. Bioinformatic analyses have revealed lower eukaryotes with a ProRS architecture reminiscent of E. coli. These eukaryotes encode a canonical ProRS with a fused N terminal ProXp-ala domain. Because many organisms with this understudied ProRS structure are parasites such as Plasmodium falciparum, Leishmania tarentolae, and Trypanosoma brucei, potential nuances in tRNA recognition and editing mechanism hold promise for drug targeting. Inhibition of Trypanosoma brucei (Tb) ProRS editing, for example, may provide a cure for African Sleeping Sickness while avoiding the human system entirely. In this work, we attempted to overexpress and purify full-length Tb ProRS for the first time in E. coli. While purification of the full-length construct was challenging due to poor solubility and low yields, the individual ProXp-ala and ΔProXp-Ala ProRS constructs were generated via SLIM-PCR, expressed, and purified with appreciable yield. The Tb ΔProXp-Ala ProRS enzyme activity was probed via aminoacylation reactions. Pure Tb tRNAPro was generated by in vitro transcription and used in aminoacylation reactions with the Tb ProRS domain to generate Pro-tRNAPro. Flexizyme charging was used to generate Tb Ala-tRNAPro. Deacylation assays were performed with the purified Tb ProXp-ala domain to provide preliminary kinetic data demonstrating the editing capabilities of Tb ProRS. Although these assays provide no explanation for the selective pressure driving this fused architecture, they do provide preliminary evidence that Tb ProXp-ala is an Ala-tRNAPro deacylase in vitro. Comparison to other trans editing factors revealed that the isolated Tb ProXp-ala domain is a weaker deacylase; however, the presence of the fused ProRS domain may be required for more robust deacylation activity and future work will address this hypothesis. Overall, we have demonstrated that the isolated Tb ProRS domains—both behave as predicted by bioinformatic analysis and provide further impetus for the purification of the full-length protein.

Description

Keywords

Trypanosomiasis, aminoacyl-tRNA synthetase, transfer RNA, deacylation, Amino acids

Citation